Pharmaceuticals and Medical Devices Agency

Events and Symposia

Public comments

What's new

October 1, 2026

Int

New

PMDA-ATC Training Materials have been updated
September 30, 2026

Safety

New

MHLW Pharmaceuticals and Medical Devices Safety Information No.431 posted
September 30, 2026

Int

New

“For Industry - for development in Japan “ Updated.
September 30, 2026

Review

New

"Consultations" Updated
September 30, 2026

Events

New

Report of PMDA-ATC Generic Drugs Review Seminar 2026
September 30, 2026

Int

New

PMDA Updates (2026 No.3) posted
September 29, 2026

Safety

New

PMDA Risk Communications: Ibuprofen L-Lysine,etc. posted
September 29, 2026

Safety

New

Revisions of PRECAUTIONS: Azathioprine, etc. posted
September 29, 2026

Review

New

English Translation of Review Report: Jivi (Partial Change Approval)
September 28, 2026

RS

New

Regulatory Science Activity Report updated
September 18, 2026

Review

SaMD page updated (guide revised, seminar videos and materials published, consultation schedule updated)
September 18, 2026

Events

PMDA-ATC MRCT/GCP Inspection Seminar 2027 applications open
September 17, 2026

Review

CDx approved for identifying eligible patients (Updated)
September 17, 2026

JP

Implementation of PDG harmonized texts into Japanese Pharmacopoeia (Monographs) updated
September 17, 2026

Review

List of Approved Medical Devices: April 2004 to December 2025

Back number

Currently, there is no applicable information.

Back number

Services of PMDA

Reviews and Related Services

Clinical trials, reviews, consultations, compliance assessments, and inspections concerning applications for drugs, medical devices, regenerative medical products, etc.

Post-marketing Safety Measures

Collection and provision of information regarding post-marketing safety and scientific research and analyses on data collected.

Relief Services for Adverse Health Effects

Relief Systems for Adverse Drug Reactions.

Regulatory Science

Regulatory science research, the Science Board, projects across multi-offices in PMDA, and standards development (e.g., Japanese Pharmacopoeia, medical device standards).

International Activities

International harmonization activities such as collaboration with overseas regulatory authorities and international organizations, participation in international meetings including ICH, and activities related to Asia Training Center.